Lung allograft dysfunction correlates with γ-interferon gene expression in bronchoalveolar lavage

Journal of Heart and Lung Transplantation

Volumn 18, Issue 7, 1999, Pages 627-636

  Ross, David J ^a,e   Moudgil, Asha ^b   Bagga, Arvind ^b   Toyoda, Mieko ^b   Marchevsky, Alberto M ^c   Kass, Robert M ^d,e   Jordan, Stanley C ^b  

^a Division of Pulmonary and Critical Care Medicine   (United States)

^b Transplant Immunol/Pediat N   (United States)

^c Division of Anatomic Pathology   (United States)

^d Division of Cardiothoracic Surgery   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2;

ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HELPER CELL; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SPIROMETRY;

ACUTE DISEASE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-2; LUNG TRANSPLANTATION; MALE; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SPIROMETRY; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032780209     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00007-8     Document Type: Article

References (39)

1. Scott J.P., Higenbottam T.W., Sharples L., et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation. 51:1991;813.
2. Sharples L.D., Scott J.P., Dennis C., et al. Risk factors for surveillance after combined heart-lung transplantation: the first 100 patients. Transplantation. 57:1994;218.
3. Sharples L.D., Tamm M., McNeil K., et al. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation - early risk factors. Transplantation. 61:1996;560.
4. Yousem S.A., Dauber J.A., Keenan R., et al. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation. 52:1991;306.
5. Sibley R.K., Berry G.J., Tazelaar H.D. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplantation. 12:1993;308.
6. Yousem S.A. Significance of clinically silent untreated mild acute cellular rejection in lung allograft recipients. Human Path. 27:1996;269.
7. Dallman M.J., Wood K.J., Morris P.J. Specific cytotoxic T cells are found in the non-rejected kidneys of blood-transfused rats. J Exp Med. 165:1987;566.
8. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 136:1986;2348.
9. Del Prete G.F., De Carli M., Mastromauro C., et al. Purified protein derivative (PPD) of Mycobacterium tuberculosis and excretory-secretory antigen(s) (TES) of Toxacara canis expand in in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profiles of cytokine production. J Clin Invest. 88:1991;346.
10. Yssel H., de Waal Malefyt R., Roncarolo M.-G., et al. Interleukin 10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol. 149:1992;2378.
11. Chen N., Gao Q., Field E.H. Prevention of Th1 responses is critical for tolerance. Transplantation. 61:1996;1076.
12. Gao Q., Chen N., Rouse T.M., Field E.H. The role of IL-4 in the induction phase of allogeneic neonatal tolerance. Transplantation. 62:1996;1847.
13. Field E.H., Gao Q., Chen N., Rouse T.M. Balancing the immune system for tolerance. Transplantation. 64:1997;1-7.
14. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection Lung Rejection Study Group . J Heart Lung Transplant. 15:1996;1.
15. Standardization of spirometry - 1987 update. Am Rev Respir Dis. 136:1987;1285-1298.
16. Hosenpud J.D., Bennett L.E., Keck B.M., et al. The registry of the International Society for Heart and Lung Transplantation: fourteenth official report - 1997. J Heart Lung Transplantation. 16:1997;691.
17. Chaparro C., Chamberlain D., Maurer J., et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients. Chest. 110:1996;1150.
18. Siddiqui M.T., Garrity E.R., Husain A.N. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients? Human Pathol. 27:1996;714.
19. Ross DJ, Marchevsky ?, Kramer M, et al. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J Heart Lung Transplantation 1997;16:832.
20. Ross DJ, Kass RM. Monitoring for lung allograft rejection. Textbook of Heart and Lung Transplantation, WB Saunders, 1998; in press.
21. Gabbay E., Dark J.H., Ashcroft, Corris P.A. Cryptogenic organizing pneumonia is an important cause of graft dysfunction and should be included in the classification of pulmonary allograft rejection (letter to the Editor). J Heart Lung Transplant. 17:1998;231-232.
22. Macatonia S.E., Hsieh C.-S., Murphy K.M., O'Garra A. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from Iβ transgenic mice: IL-2 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. Int Immunol. 5:1993;1119.
23. Peleman R., Wu J., Fargeas C., Delespesse G. Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells. J Exp Med. 170:1989;1751.
24. Martinez O.M., Gibbons R., Garovoy M.R., Aronson F.R. IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells. J Immunol. 144:1990;2211.
25. Fiorentino D.F., Zlotnik A., Vieiera P., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 146:1991;3444.
26. Zuo X.-J., Matsumura Y., Prehn J., et al. Cytokine gene expression in rejecting and tolerant rat lung allograft models: analysis by RT-PCR. Transplant Immunol. 3:1995;151-161.
27. Maeda H., Takata M., Takahashi S., Ogoshi S., Fujimoto S. Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse. Int Immunol. 6:1994;855.
28. Lang T., Krams S.M., Martinez O.M. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation. 62:1996;776-780.
29. 1 ratio is a marker for human lung allograft rejection. J Invest Med. 42:1994;652.
30. 486IL-2. Transplant Proc. 23:1991;314-315.
31. Iacono A., Dauber J., Keenan R., et al. Interleukin 6 and interferon-γ gene expression in lung transplant recipients with refractory acute cellular rejection. Transplantation. 64:1997;263-269.
32. Burlingham W.J., Grailer A.P., Hullett D.A., Sollinger H.W. Inhibition of both MLC and in vitro IgG memory response to tetanus toxoid by RS-61443. Transplantation. 51:1991;545-547.
33. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the cotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007.
34. Verleden G.M., Dupont L., Lamont J., et al. Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection (letter to the Editor). J Heart Lung Transplant. 17:1998;231-232.
35. Moudgil A, Bagga A, Toyoda M, Nicolaidou E, Jordan SC, Ross DJ. Expression of mRNA for γ-IFN and ICAM-1 in bronchoalveolar lavage fluid correlates with acute allograft rejection in lung transplant recipients. Clin Immunol 1999; in press.
36. Aslanzadeh J., Padilla B.B., Shanley J.D. Evaluation of PCR and nested PCR for laboratory diagnosis of hepatitis C virus infection. Mol Cell Probes. 10:1996;173-178.
37. Belec L., Authier F.J., Chazaud B., Piedouillet C., Barlovatz-Meimon G., Gherardi R.K. Interleukin (IL)-1 beta and IL-1 beta mRNA expression in normal and diseased skeletal muscle assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction. J Neuropathol Exp Neurol. 56:1997;651-653.
38. Sardi I., Piazzini M., Ponchietti R., Fatini C., Di Loro F., Guazzelli R. The use of RT-"nested" PCR of prostate specific antigen to detect hematogenous neoplastic cells in patients with prostate adenocarcinoma. J Mol Med. 75:1997;751-757.
39. Pfeffer M., Proebster B., Kinney R.M., Kaaden O.R. Genus-specific detection of alpha viruses by a semi-nested reverse transcription-polymerase chain reaction. Am J Trop Med Hygiene. 57:1997;709-718.